Y-27632
RHO/ROCK pathway inhibitor; Inhibits ROCK1 and ROCK2
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Inhibit cell death of stem cells derivatives when plating from frozen stocks for terminal differenti
Easy to dissolve in DMSO, consistency in molarity and efficacy.
Review Date: 31 Oct 2023 | STEMCELL Technologies Inc.
Y-27632 is a cell-permeable, highly potent and selective inhibitor of Rho-associated, coiled-coil containing protein kinase (ROCK). Y-27632 inhibits both ROCK1 (Ki = 220 nM) and ROCK2 (Ki = 300 nM) by competing with ATP for binding to the catalytic site. (Davies et al., Ishizaki et al.)
REPROGRAMMING
- Direct lineage reprogramming of fibroblasts to mature neurons, in combination with CHIR99021, RepSox, Forskolin, SP600125, Gö6983 and Valproic Acid (Hu et al.).
MAINTENANCE AND SELF-RENEWAL
- Enhances survival of human embryonic stem (ES) cells when they are dissociated to single cells by preventing dissociation-induced apoptosis (anoikis), thus increasing their cloning efficiency (Watanabe et al.).
- Improves embryoid body formation using forced-aggregation protocols (Ungrin et al.).
- Increases the survival of cryopreserved single human ES cells after thawing (Li et al.).
- Blocks apoptosis of mouse ES-derived neural precursors after dissociation and transplantation (Koyanagi et al.).
DIFFERENTIATION:
- Improves survival of human ES cell monolayers at the initiation of differentiation protocols (Rezania et al.)